Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
Multiple Sclerosis Journal - Experimental, Translational and Clinical · 2021-10 · 7 (4)
DOI: 10.1177/20552173211052656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal - Experimental, Translational and Clinical, online erschienen am 26.11.2021. Verfasst von Vyanka Redenbaugh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Objective
Determine the utility of aquaporin 4 IgG (AQP4-IgG) testing (live cell-based assay) for Neuromyelitis Optica Spectrum Disorders (NMOSD).
Methods
We included Mayo Clinic patients (1/1/2018-12/31/2019) tested for serum AQP4-IgG by live cell-based flow-cytometric assay. Medical records were reviewed to assess if patients fulfilled 2015 NMOSD criteria.
Results
Of 1371 patients tested, 41 were positive (3%) and all fulfilled NMOSD criteria with AQP4-IgG (specificity = 100%). Only 10/1330 testing negative met NMOSD criteria without AQP4-IgG (sensitivity = 80%) and seven of these 10 were MOG-IgG positive.
Conclusions
AQP4-IgG by live cell-based assay was highly specific and without false positives in a high throughput setting.
Autor:innen und Institutionen
- Departments of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA.
- Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
- Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA.
- Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
ORCID-Profile: Vyanka Redenbaugh, Elia Sechi, A Sebastian Lopez Chiriboga, Sean J Pittock, Eoin P Flanagan
Förderung
- NINDS NIH HHS
Zitieren
APA
Redenbaugh, V., Montalvo, M., Sechi, E., Buciuc, M., Fryer, J. P., McKeon, A., Lennon, V. A., Mills, J. R., Weinshenker, B. G., Wingerchuk, D. M., Chen, J. J., Tariq Bhatti, M., Lopez Chiriboga, A. S., Pittock, S. J., & Flanagan, E. P. (2021). Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 7(4). https://doi.org/10.1177/20552173211052656
Vancouver
Redenbaugh V, Montalvo M, Sechi E, Buciuc M, Fryer JP, McKeon A, et al. Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2021;7(4). doi:10.1177/20552173211052656
BibTeX
@article{Redenbaugh2021,
author = {Redenbaugh, Vyanka and Montalvo, Mayra and Sechi, Elia and Buciuc, Marina and Fryer, James P and McKeon, Andrew and Lennon, Vanda A and Mills, John R and Weinshenker, Brian G and Wingerchuk, Dean M and Chen, John J and Tariq Bhatti, M and Lopez Chiriboga, A Sebastian and Pittock, Sean J and Flanagan, Eoin P},
title = {Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders},
journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
year = {2021},
volume = {7},
number = {4},
doi = {10.1177/20552173211052656}
}
EUVIMED